Advancing the pathway to allogeneic hematopoietic stem cell transplantation through a physician-nurse coordinator system in patients with acute leukemia

通过医生-护士协调系统推进急性白血病患者异基因造血干细胞移植的进程

阅读:1

Abstract

Acute leukemia is an aggressive hematologic malignancy with a historically poor prognosis. The introduction of allogeneic hematopoietic stem cell transplantation (allo-HSCT) has substantially improved patient outcomes, offering the potential for a cure. However, prolonged preparation time for allo-HSCT can increase the risk of disease relapse or complications from consolidation chemotherapy. To address this issue, we established a physician‒nurse coordinator system to streamline and organize the preparation of patients and donors for allo-HSCT. In this single-center study, we combined prospective and historical cohorts. Adult leukemia patients (aged 18 years or older) who underwent allo-HSCT at Siriraj Hospital, Bangkok, Thailand, were enrolled. The primary aim was to compare the timing and rate of transplantation before and after the implementation of the physician‒nurse coordinator system. Between January 1, 2018, and February 1, 2024, 105 patients were enrolled. Patients diagnosed after August 1, 2021, were categorized into the physician-nurse coordinator group, resulting in 61 patients in the conventional group and 44 in the physician‒nurse coordinator group. The median (Q1, Q3) time from diagnosis to transplantation was significantly shorter in the physician‒nurse coordinator group than in the conventional group (9.0 [6.0, 14.0] months vs. 13.0 [7.5, 19.5] months; P = 0.029). Similarly, the time from diagnosis to complete preparation was significantly shorter (7.0 [5.0, 12.8] months vs. 11.0 [6.5, 17.0] months; P = 0.022). However, improvements in the transplantation rate within 6 months, relapse during transplant preparation, and post-transplantation outcomes did not reach statistical significance. Implementing a physician‒nurse coordinator system significantly reduced the time from diagnosis to allo-HSCT in acute leukemia patients. Our findings suggest that such coordinated care models could be valuable in optimizing the management of acute leukemia patients eligible for transplantation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。